0ADL Stock Overview
Engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
GE HealthCare Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$70.63 |
| 52 Week High | US$92.38 |
| 52 Week Low | US$64.49 |
| Beta | 1.38 |
| 1 Month Change | 9.53% |
| 3 Month Change | -21.62% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -17.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0ADL | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0.4% | 1.8% | -0.2% |
| 1Y | n/a | 7.9% | 3.3% |
Return vs Industry: Insufficient data to determine how 0ADL performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how 0ADL performed against the UK Market.
Price Volatility
| 0ADL volatility | |
|---|---|
| 0ADL Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 3.4% |
Stable Share Price: 0ADL's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0ADL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | 53,000 | Pete Arduini | www.gehealthcare.com |
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health products.
GE HealthCare Technologies Inc. Fundamentals Summary
| 0ADL fundamental statistics | |
|---|---|
| Market cap | US$32.75b |
| Earnings (TTM) | US$2.18b |
| Revenue (TTM) | US$19.80b |
Is 0ADL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0ADL income statement (TTM) | |
|---|---|
| Revenue | US$19.80b |
| Cost of Revenue | US$11.48b |
| Gross Profit | US$8.32b |
| Other Expenses | US$6.13b |
| Earnings | US$2.18b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.77 |
| Gross Margin | 42.00% |
| Net Profit Margin | 11.03% |
| Debt/Equity Ratio | 93.0% |
How did 0ADL perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/30 14:50 |
| End of Day Share Price | 2025/05/28 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
GE HealthCare Technologies Inc. is covered by 28 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Navann Ty Dietschi | BNP Paribas Exane |
| Craig Bijou | BofA Global Research |
| Michael Gorman | BTIG |